Sanofi-Aventis is opposing certification of a Taxotere class action lawsuit seeking to represent all women in Louisiana who suffered long-term or permanent hair loss after using the chemotherapy drug.…
More than 1,100 Taxotere lawsuits have been filed by women nationwide who say they suffered permanent hair loss due to the side effects of the chemotherapy drug.…
A motion has been filed to certify a Taxotere class action lawsuit over permanent hair loss problem experienced by women who received the controversial breast cancer drug.…
A Science Day for Taxotere litigation is scheduled for May 3, at which point the court will hear presentations on Taxotere chemotherapy and its links to permanent hair loss.…
More than 850 lawsuits have already been filed on behalf of women nationwide, who allege they have been left with permanent hair loss problems from Taxotere, a controversial breast cancer drug that plaintiffs indicate is no more effective than other treatment options, which do not carry the same risks.…
French officials are conducting a safety review of Taxotere following at least five deaths linked to the drug since last summer.…
After undergoing breast cancer chemotherapy with the drug Taxotere, a California woman has filed a lawsuit alleging Sanofi-Aventis failed to warn about the risk of permanent alopecia, providing false and misleading information that suggested hair would regrow following treatment.…
A Plaintiff Fact Sheet has been approved for Taxotere lawsuits, which is designed to streamline the exchange of information about permanent hair loss experienced by women nationwide after exposure to the controversial breast cancer drug.…
The process for women to bring product lawsuits over continuing hair loss caused by Taxotere will be streamlined, with the filing of a Master Long Form Complaint and Short Form Complaint in the federal MDL, where hundreds of claims are being pursued against the drug maker for failing to warn consumers and the medical community.…
Sanofi-Aventis allegedly withheld information about the risk of permanent baldness from the breast cancer drug Taxotere, even though alternative treatments were just as effective and did not carry the same risk, according to one of the latest in a growing number of lawsuits being pursued by women nationwide.…
